Selective targeting of the mTORC1/2 protein kinase complexes leads to antileukemic effects in vitro and in vivo
Katja Schuster(The University of Texas Southwestern Medical Center), Pier Paolo Scaglioni(University of Cincinnati)
Cited by 17
Related Papers
Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer
|Nature Communications|2022|168